Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2021-11-18 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company (Inbiogen) detailing a decision for a third-party capital increase (유상증자결정). This type of filing is a formal regulatory announcement regarding changes to the company's capital structure, specifically the issuance of new shares. In the context of the provided categories, this fits best under 'Share Issue/Capital Change' (SHA), as it details the issuance of new shares, the purpose of the capital raise, and the specific terms of the third-party allocation.
2021-11-18 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '인바이오젠' (Inbiogen) covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, company overview, capital structure, and management details, which is characteristic of a formal quarterly financial report filed with the Korean financial authorities (Financial Services Commission/Korea Exchange). 9M 2021
2021-11-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the acquisition of convertible bonds and changes in shareholding percentages by the reporting entity and its special relations. This falls under the category of Major Shareholding Notification.
2021-09-07 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the 'Result of Issuance of Convertible Bonds' (유상증자 또는 주식관련사채 등의 발행결과). This document details the finalization of a capital-raising event (issuance of convertible bonds), which falls under the category of capital structure changes and financing activities. According to the provided definitions, 'SHA' (Share Issue/Capital Change) is the most appropriate category for announcements regarding new share issues or capital changes, including convertible debt instruments.
2021-08-31 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a formal 'Correction Report' (정정신고) regarding a previously filed 'Major Report' (주요사항보고서) concerning the issuance of convertible bonds (전환사채권 발행결정). It details specific changes to the bond amount, conversion price, and call option terms. In the context of Korean financial filings (DART system), this is a regulatory filing that updates a previous material event disclosure. Since it is a specific regulatory update regarding capital structure and financing, it falls under the 'Regulatory Filings' category.
2021-08-30 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 인바이오젠' covering the period from 2021-01-01 to 2021-06-30. It contains detailed financial and corporate information, including business overview, management changes, capital structure, and shareholding details. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2021
2021-08-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.